• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Tei指数作为评估实验性尿毒症心肌病模型早期预测指标的作用。

The role of Tei index as an early predictor for evaluating experimental uremic cardiomyopathy model.

作者信息

Cheng Shi, Lu Wei, Xu Jiarui, Yu Yong, Fang Yi, Tan Xiao, Chen Ruizhen, Shen Bo, Ding Xiaoqiang, Xie Yeqing

机构信息

Department of Nephrology, Zhongshan Hospital, Fudan University, No.180, Fenglin Road, Xuhui District, Shanghai, 200032, China.

Shanghai Key Laboratory of Kidney Disease and Dialysis, Shanghai, 200032, China.

出版信息

BMC Nephrol. 2025 Jul 1;26(1):327. doi: 10.1186/s12882-025-04203-2.

DOI:10.1186/s12882-025-04203-2
PMID:40597763
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12219627/
Abstract

BACKGROUND

Uremic cardiomyopathy (UCM) remains the leading cause of cardiovascular mortality in patients with end-stage renal disease (ESRD). Experimental animal models serve as essential tools for elucidating the potential mechanism underlying UCM. However, experimental UCM models are often challenged by inter-individual variability and inconsistent success rates. Reliable phenotypes are not guaranteed by current animal models of UCM. In this study, Tei index from echocardiography was investigated for its potential value in construction of murine UCM model based on 5/6 nephrectomy (Nx).

METHODS

Comprehensive echocardiographic assessment, measurement of blood pressure and serum creatinine, histological analysis, and quantitative polymerase chain reaction (qPCR) were performed to reveal the relationship between Tei index and construction of UCM model.

RESULTS

The Tei index was significantly elevated in Nx mice despite preserved cardiac function and structural integrity at 8 weeks post-nephrectomy. A longitudinal follow-up to the 12 week revealed that the Nx mice with higher Tei index (Nx HT) presented distinct features of hemodynamic remodeling, left ventricular hypertrophy and diastolic dysfunction. Furthermore, pronounced myocardial hypertrophy and extensive myocardial interstitial fibrosis were confirmed in the Nx HT group.

CONCLUSIONS

This study validates the Tei index as a sensitive and non-invasive parameter for the early evaluation and prediction of UCM murine model induced by 5/6 nephrectomy.

摘要

背景

尿毒症心肌病(UCM)仍然是终末期肾病(ESRD)患者心血管死亡的主要原因。实验动物模型是阐明UCM潜在机制的重要工具。然而,实验性UCM模型常常受到个体间差异和成功率不一致的挑战。目前的UCM动物模型无法保证可靠的表型。在本研究中,基于超声心动图的Tei指数在基于5/6肾切除术(Nx)构建小鼠UCM模型中的潜在价值进行了研究。

方法

进行全面的超声心动图评估、血压和血清肌酐测量、组织学分析以及定量聚合酶链反应(qPCR),以揭示Tei指数与UCM模型构建之间的关系。

结果

尽管肾切除术后8周心脏功能和结构完整性得以保留,但Nx小鼠的Tei指数显著升高。对12周的纵向随访显示,Tei指数较高的Nx小鼠(Nx HT)表现出明显的血流动力学重塑、左心室肥厚和舒张功能障碍特征。此外,Nx HT组证实有明显的心肌肥厚和广泛的心肌间质纤维化。

结论

本研究验证了Tei指数作为5/6肾切除诱导的UCM小鼠模型早期评估和预测的敏感且非侵入性参数。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c3/12219627/6b8f0836c3d6/12882_2025_4203_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c3/12219627/aa2dc3830cb8/12882_2025_4203_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c3/12219627/56156fe3f807/12882_2025_4203_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c3/12219627/d00d1119f85d/12882_2025_4203_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c3/12219627/6e60e549d9a8/12882_2025_4203_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c3/12219627/24fb98ff7860/12882_2025_4203_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c3/12219627/fbe9b55968da/12882_2025_4203_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c3/12219627/6b8f0836c3d6/12882_2025_4203_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c3/12219627/aa2dc3830cb8/12882_2025_4203_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c3/12219627/56156fe3f807/12882_2025_4203_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c3/12219627/d00d1119f85d/12882_2025_4203_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c3/12219627/6e60e549d9a8/12882_2025_4203_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c3/12219627/24fb98ff7860/12882_2025_4203_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c3/12219627/fbe9b55968da/12882_2025_4203_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/66c3/12219627/6b8f0836c3d6/12882_2025_4203_Fig7_HTML.jpg

相似文献

1
The role of Tei index as an early predictor for evaluating experimental uremic cardiomyopathy model.Tei指数作为评估实验性尿毒症心肌病模型早期预测指标的作用。
BMC Nephrol. 2025 Jul 1;26(1):327. doi: 10.1186/s12882-025-04203-2.
2
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.
3
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
4
Genetic Atypical Hemolytic-Uremic Syndrome遗传性非典型溶血性尿毒症综合征
5
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
6
Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.早期转介策略在管理有肾脏疾病标志物的人群中的应用:对临床有效性、成本效益和经济分析证据的系统评价。
Health Technol Assess. 2010 Apr;14(21):1-184. doi: 10.3310/hta14210.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
8
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
9
Systematic review on urine albumin testing for early detection of diabetic complications.关于尿白蛋白检测用于早期发现糖尿病并发症的系统评价。
Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. doi: 10.3310/hta9300.
10
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.

本文引用的文献

1
Roles of AhR/CYP1s signaling pathway mediated ROS production in uremic cardiomyopathy.AhR/CYP1s 信号通路介导的 ROS 产生在尿毒症性心肌病中的作用。
Toxicol Lett. 2024 May 15;396:81-93. doi: 10.1016/j.toxlet.2024.04.005. Epub 2024 Apr 24.
2
Echocardiographic manifestations in end-stage renal disease.终末期肾病的超声心动图表现。
Heart Fail Rev. 2024 Mar;29(2):465-478. doi: 10.1007/s10741-023-10376-5. Epub 2023 Dec 10.
3
Cardiomyopathy in chronic kidney disease: clinical features, biomarkers and the contribution of murine models in understanding pathophysiology.
慢性肾脏病中的心肌病:临床特征、生物标志物及小鼠模型在理解病理生理学中的作用
Clin Kidney J. 2023 Apr 18;16(11):1786-1803. doi: 10.1093/ckj/sfad085. eCollection 2023 Nov.
4
Myocardial performance index and cardiovascular diseases.心肌做功指数与心血管疾病。
Echocardiography. 2023 Jul;40(7):720-725. doi: 10.1111/echo.15628. Epub 2023 May 29.
5
Cardiac Metabolism in Heart Failure and Implications for Uremic Cardiomyopathy.心力衰竭中心脏代谢及对尿毒症性心肌病的影响。
Circ Res. 2023 Apr 14;132(8):1034-1049. doi: 10.1161/CIRCRESAHA.123.321759. Epub 2023 Apr 13.
6
Identification of early cardiac dysfunction and heterogeneity after pressure and volume overload in mice by high-frequency echocardiographic strain imaging.通过高频超声心动图应变成像识别小鼠压力和容量超负荷后的早期心脏功能障碍和异质性。
Front Cardiovasc Med. 2023 Jan 13;9:1071249. doi: 10.3389/fcvm.2022.1071249. eCollection 2022.
7
Non-invasive assessment of HFpEF in mouse models: current gaps and future directions.无创评估小鼠模型中的 HFpEF:当前的差距和未来的方向。
BMC Med. 2022 Oct 14;20(1):349. doi: 10.1186/s12916-022-02546-3.
8
Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease.慢性肾脏病患者的心血管疾病流行病学和风险。
Nat Rev Nephrol. 2022 Nov;18(11):696-707. doi: 10.1038/s41581-022-00616-6. Epub 2022 Sep 14.
9
Pro-oxidative priming but maintained cardiac function in a broad spectrum of murine models of chronic kidney disease.慢性肾病多种鼠模型中促氧化预处理但维持心功能。
Redox Biol. 2022 Oct;56:102459. doi: 10.1016/j.redox.2022.102459. Epub 2022 Aug 30.
10
Cardiac metabolic remodelling in chronic kidney disease.慢性肾脏病中的心脏代谢重塑
Nat Rev Nephrol. 2022 Aug;18(8):524-537. doi: 10.1038/s41581-022-00576-x. Epub 2022 May 30.